The latest skin cancer and melanoma news
Disrupting cancer pathway could enhance new immunotherapies
Understanding how to overrule a signalling pathway that can cause treatments to fail in metastatic…
The latest skin cancer and melanoma news
Understanding how to overrule a signalling pathway that can cause treatments to fail in metastatic…
Young women may be up on the latest fashions and trends as they prepare for…
Ian Olver, University of South Australia Keytruda® (pembrolizumab) is the latest drug to be registered…
People over 65 are around seven times more likely to develop malignant melanoma compared to 40 years…
By Stephen Luntz – IFL Science. Cancer vaccines tailored-made to a patient’s individual tumour have…
By Justin Bryans, Queen Mary University of London. Pembrolizumab, an immunotherapy treatment initially approved for advanced…
A new immunotherapy drug, pembrolizumab, has become the first treatment ‘fast-tracked’ for NHS patients with…
Treating metastatic melanoma with a triple threat—including radiation therapy and two immunotherapies that target the CTLA4…
Much of the damage that ultraviolet radiation (UV) does to skin occurs hours after sun…
The importance of RNA editing in melanoma has been demonstrated by scientists at The University…